Trial Profile

Phase 4 Study of YUTIQ (Fluocinolone Acetonide Intravitreal Implant) 0.18 mg in the Treatment of Chronic Non-Infectious Posterior Segment Uveitis (Intraocular Inflammation Study)

Status: Active, no longer recruiting

Phase of Trial: Phase IV

Latest Information Update: 26 May 2026

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

08 May 2026 According to a ANI Pharmaceuticals media release, the company is on a track to announce results from this trial in NIU-PS at a medical conference in the third quarter of 2026..
04 Jan 2024 Status changed from recruiting to active, no longer recruiting, according to an Alimera Sciences media release.
04 Jan 2024 According to an Alimera Sciences media release, company announced completion of enrollment of Synchronicity Study. Initial readout from this study in the second half of next year.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com